0      0

28th Annual North American Cystic Fibrosis Conference

W24: NT: Innovative Approaches to CF Outcomes & Therapies

Oct 11, 2014 2:30pm ‐ Oct 11, 2014 4:15pm

Standard: $49.99


In this session the most recent data of clinical trials evaluating CFTR mutation-specific pharmacological therapeutics will be presented. Also, promising novel molecular therapies targeting CFTR mutations will be discussed.

Learning Objectives:
  • Describe current status of clinical trials investigating mutation-specific therapies
  • Describe the clinical relevance of biomarkers
  • Summarize novel mutation-targeted molecular therapies


You must be logged in and own this session in order to post comments.